Compare, Analyse Novartis with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NOVARTIS vs ADCOCK INGRAM (S. Africa) - Comparison Results

NOVARTIS     Change

Novartis is a 76% subsidiary of Novartis AG - Switzerland and has a countrywide presence in the healthcare business. While pharmaceuticals contributes 70% to total revenues (FY10), generics (6%), consumer healthcare i.e. OTC (14%) and animal health (... More

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 NOVARTIS   ADCOCK INGRAM
EQUITY SHARE DATA
    NOVARTIS
Mar-19
ADCOCK INGRAM
Jun-14
NOVARTIS/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs980309-   
Low Rs600223-   
Sales per share (Unadj.) Rs198.791.9-  
Earnings per share (Unadj.) Rs21.0-23.2-  
Cash flow per share (Unadj.) Rs22.3-19.2-  
Dividends per share (Unadj.) Rs10.000-  
Dividend yield (eoy) %1.30-  
Book value per share (Unadj.) Rs307.572.1-  
Shares outstanding (eoy) m24.69168.78-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.02.9 137.4%   
Avg P/E ratio x37.7-11.5 -328.2%  
P/CF ratio (eoy) x35.5-13.9 -256.2%  
Price / Book Value ratio x2.63.7 69.7%  
Dividend payout %47.70-   
Avg Mkt Cap Rs m19,50844,866 43.5%   
No. of employees `0000.64.3 13.5%   
Total wages/salary Rs m1,1712,816 41.6%   
Avg. sales/employee Rs Th8,445.43,612.0 233.8%   
Avg. wages/employee Rs Th2,015.7655.9 307.3%   
Avg. net profit/employee Rs Th891.0-910.1 -97.9%   
INCOME DATA
Net Sales Rs m4,90715,506 31.6%  
Other income Rs m783109 720.7%   
Total revenues Rs m5,68915,615 36.4%   
Gross profit Rs m123-2,687 -4.6%  
Depreciation Rs m32669 4.8%   
Interest Rs m16420 3.8%   
Profit before tax Rs m858-3,668 -23.4%   
Minority Interest Rs m0-10 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m340229 148.3%   
Profit after tax Rs m518-3,907 -13.2%  
Gross profit margin %2.5-17.3 -14.4%  
Effective tax rate %39.6-6.2 -634.4%   
Net profit margin %10.6-25.2 -41.9%  
BALANCE SHEET DATA
Current assets Rs m8,05511,357 70.9%   
Current liabilities Rs m1,8506,390 29.0%   
Net working cap to sales %126.432.0 394.7%  
Current ratio x4.41.8 244.9%  
Inventory Days Days45111 40.6%  
Debtors Days Days34124 27.4%  
Net fixed assets Rs m1506,620 2.3%   
Share capital Rs m12372 171.4%   
"Free" reserves Rs m7,4690-   
Net worth Rs m7,59212,171 62.4%   
Long term debt Rs m04,277 0.0%   
Total assets Rs m9,82422,992 42.7%  
Interest coverage x54.9-7.7 -710.6%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x0.50.7 74.1%   
Return on assets %5.4-15.2 -35.8%  
Return on equity %6.8-32.1 -21.2%  
Return on capital %11.5-19.8 -58.1%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m-1,2690-   
CASH FLOW
From Operations Rs m-1,9431,324 -146.8%  
From Investments Rs m2,742-406 -674.8%  
From Financial Activity Rs m-2983,882 -7.7%  
Net Cashflow Rs m5014,799 10.4%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.26 Rs / ZAR

Compare NOVARTIS With: ACTAVIS (US)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare NOVARTIS With: ELDER PHARMA  ALEMBIC PHARMA  VENUS REMEDIES  FRESENIUS KABI ONCO.  SANOFI INDIA  



Today's Market

Sensex Opens Higher; Healthcare Stocks Lead(09:30 am)

Asian stock markets are lower today as Chinese and Hong Kong shares fall. The Shanghai Composite is off 0.2% while the Hang Seng is down 0.8%.

Related Views On News

NOVARTIS Announces Quarterly Results (3QFY20); Net Profit Down 39.9% (Quarterly Result Update)

Feb 17, 2020 | Updated on Feb 17, 2020

For the quarter ended December 2019, NOVARTIS has posted a net profit of Rs 77 m (down 39.9% YoY). Sales on the other hand came in at Rs 1 bn (down 13.4% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

NOVARTIS Announces Quarterly Results (1QFY20); Net Profit Down 92.1% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, NOVARTIS has posted a net profit of Rs 8 m (down 92.1% YoY). Sales on the other hand came in at Rs 1 bn (down 20.8% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

More Views on News

Most Popular

These 5 Smallcaps Deserve a Place in Your Coffee Can Portfolio (Profit Hunter)

Jul 28, 2020

When it comes to quality stocks, doing less is more.

Before You Buy Your First Electric Vehicle Consider Buying this Stock (Profit Hunter)

Jul 29, 2020

As competition intensifies in the electric vehicle space, only few will create huge wealth over the years.

Large Opportunities Are Coming Our Way

Aug 5, 2020

Kenneth Andrade tells us why stocks will bounce back strongly and what he's bullish on.

Elon Musk Gives Us a Trading Opportunity (Fast Profits Daily)

Jul 28, 2020

Elon Musk made a statement recently which I believe, gives us a fast profit trading opportunity.

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2020
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

NOVARTIS SHARE PRICE


Aug 10, 2020 09:53 AM

TRACK NOVARTIS

  • Track your investment in NOVARTIS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON NOVARTIS

NOVARTIS - ELDER PHARMA COMPARISON

COMPARE NOVARTIS WITH

FEATURED VIDEOS

Can You Win a Stock Market Championship Using My Penny Stock Strategy? Let's Find Out

How to Use Price Action to Find High Conviction Trading Ideas

Why This Attractive 'Silver' Stock With 9% Dividends Is Not a Buy

A Zero Loss Strategy that Also Maximizes Returns in Volatile Stock Markets

More Featured Videos

MARKET STATS